Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propen-1-yl]-, hydrochloride (1:2), 99%, 25g

Ethyl 3-oxo-2-(p-tolyloxy)butyrate, 95.0%, 1g

Systèmes de dialyse Spectra/Por® Float-A-Lyzer® G2 Volume de remplissage 1 ml, 300000 dalton(s), 12 pièce(s)

6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]-1,4-dihydroquinazolin-4-one, 95%, 100mg

6-Bromo-1H-indazole-4-carbaldehyde, 98%, 500mg

2-Dodecyl-p-cresol>98.0%(GC)10g

(3S,4R)-3-FLUOROOXAN-4-AMINE HCL, 95.0%, 500mg

3-Amino-3-(3-methoxyphenyl)propanenitrile hydrochloride, 95.0%, 250mg

2-Methyl-6-(pyrrolidin-2-yl)pyridine, 98%, 250mg

4-Bromo-3-chloro-2-fluoro-pyridine, 97.0%, 100g

TERT-BUTYL 4-(HYDRAZINECARBONYL)-4-METHYLPIPERIDINE-1-CARBOXYLATE, 90.0%, 500mg

5-(4-Formylphenyl)nicotinic acid, 95.0%, 10g

(1R,4S)-2-Azabicyclo[2.2.1]heptan-3-one, 95%, 5g